| Index | — | P/E | — | EPS (ttm) | -2.74 | Insider Own | 3.13% | Shs Outstand | 199.35M | Perf Week | 7.38% |
| Market Cap | 1.97B | Forward P/E | 6.69 | EPS next Y | 1.48 | Insider Trans | 0.99% | Shs Float | 197.66M | Perf Month | 14.19% |
| Enterprise Value | 4.05B | PEG | — | EPS next Q | 0.31 | Short Float | 15.09% | Perf Quarter | -30.62% | ||
| Income | -546.00M | P/S | 0.54 | EPS this Y | -4.63% | Short Ratio | 6.40 | Perf Half Y | -11.61% | ||
| Sales | 3.64B | P/B | 1.46 | EPS next Y | -3.15% | ROA | -10.49% | Short Interest | 29.82M | Perf YTD | -13.39% |
| Book/sh | 6.78 | P/C | 8.26 | EPS next 5Y | 2.34% | ROE | -39.81% | 52W High | 14.76 -32.93% | Perf Year | -21.37% |
| Cash/sh | 1.20 | P/FCF | 13.80 | EPS past 3/5Y | — | ROIC | 10.03% | 52W Low | 8.32 18.99% | Perf 3Y | -67.73% |
| Dividend Est. | — | EV/EBITDA | 43.51 | Sales past 3/5Y | -2.10% 1.96% | Gross Margin | 49.52% | Volatility | 3.20% 3.56% | Perf 5Y | -82.71% |
| Dividend TTM | 0.16 (1.62%) | EV/Sales | 1.11 | EPS Y/Y TTM | — | Oper. Margin | 11.69% | ATR (14) | 0.35 | Perf 10Y | -83.02% |
| Dividend Ex-Date | Dec 26, 2025 | Quick Ratio | 1.07 | Sales Y/Y TTM | -0.76% | Profit Margin | -14.99% | RSI (14) | 60.99 | Recom | 2.66 |
| Dividend Gr. 3/5Y | 8.58% 9.86% | Current Ratio | 1.63 | EPS Q/Q | 0.00% | SMA20 | 10.12% | Beta | 0.84 | Target Price | 12.14 |
| Payout | — | Debt/Eq | 1.71 | Sales Q/Q | -4.06% | SMA50 | 2.29% | Rel Volume | 1.34 | Prev Close | 9.53 |
| Employees | 14,000 | LT Debt/Eq | 1.54 | Earnings | Nov 05 | SMA200 | -12.52% | Avg Volume | 4.53M | Price | 9.90 |
| IPO Date | Aug 12, 1987 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 49.44% 0.91% | Net Debt/EBITDA | 22.29 | Volume | 6,060,435 | Change | 3.88% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Oct-26-26 | Reiterated | Barrington Research | Outperform | $15 → $13 |
| Oct-22-26 | Reiterated | Mizuho | Neutral | $14 → $12 |
| Oct-14-26 | Reiterated | Leerink Partners | Market Perform | $10 |
| Oct-09-26 | Reiterated | Piper Sandler | Neutral | $14 → $12 |
| Sep-17-26 | Reiterated | BMO Capital | Market Perform | $13 → $10 |
| Aug-24-26 | Reiterated | Barclays | Underweight | $9.00 → $11 |
| Aug-10-26 | Reiterated | Barrington | Outperform | $17 → $15 |
| Aug-07-26 | Reiterated | BMO Capital | $12 → $13 | |
| Jul-29-26 | Reiterated | Piper Sandler | Neutral | $32 → $14 |
| Jul-08-26 | Initiated | BMO Capital | Market Perform | $12 |
DENTSPLY SIRONA Inc. develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide. It operates through four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The Connected Technology Solutions segment offers imaging equipment, motorized dental handpieces, treatment centers, and other instruments; and intraoral scanners, 3-D printers, and mills, as well as CEREC, a full-chairside economical restoration of esthetic ceramic dentistry offering. The Essential Dental Solutions segment provides motorized endodontic handpieces, files, sealers, irrigation needles, and other tools for root canal procedures; restorative products; curing light and dental diagnostic systems; ultrasonic scalers and polishers; and dental anesthetics, prophylaxis paste, dental sealants, and impression materials. The Orthodontic and Implant Solutions segment offers SureSmile, a clear aligner solution that includes whitening kits and retainers; VPro, a high frequency vibration technology device; SureSmile Simulator; DS Core platform, which creates 3D visualization of patient outcomes; dental implant products; digital dentures; crown and bridge porcelain products; bone regenerative and restorative solutions; treatment planning software; educational programs; custom abutments; tapered immediate load screws; regenerative bone growth factor; artificial teeth; and precious metal dental alloys. The Wellspect Healthcare segment offers medical devices, including catheters for urinary retention and advanced irrigation systems to help people suffering from chronic or severe constipation. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1877 and is headquartered in Charlotte, North Carolina.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 3,643 | 3,680 | 3,793 | 3,965 | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 1,839 | 1,840 | 1,835 | 1,879 | — | — | — | — | — | |
| Gross Profit | 1,804 | 1,840 | 1,958 | 2,086 | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 1,458 | 1,438 | 1,605 | 1,613 | — | — | — | — | — | |
| Research and Development | 166 | 150 | 165 | 184 | — | — | — | — | — | |
| Other Operating Expense | -246 | 0 | 1,067 | 374 | — | — | — | — | — | |
| Operating Income | 426 | 252 | -879 | -85 | — | — | — | — | — | |
| Interest Expense | 91 | 88 | 69 | 81 | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | -682 | -650 | 12 | -9 | — | — | — | — | — | |
| Net Income Before Taxes | -347 | -486 | -936 | -175 | — | — | — | — | — | |
| Income Taxes | 200 | 112 | -26 | -43 | — | — | — | — | — | |
| Consolidated Net Income | -546 | -598 | -910 | -132 | — | — | — | — | — | |
| Net Income From Continuing Operations | -547 | -598 | -910 | -132 | — | — | — | — | — | |
| Net Income | -546 | -598 | -910 | -132 | — | — | — | — | — | |
| EPS (Recurring) | -2.74 | -3.00 | -4.48 | -0.62 | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | -2.74 | -3.00 | -4.48 | -0.62 | — | — | — | — | — | |
| EPS (Diluted) | -2.74 | -3.00 | -4.48 | -0.62 | — | — | — | — | — | |
| EBITDA | 93 | -46 | -518 | 249 | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | — | — | — | — | — | — | — | — | — | |
| Price To Sales Ratio | 0.54 | 0.62 | 1.02 | 1.90 | — | — | — | — | — | |
| Gross Margin | 49.52 | 50.00 | 51.62 | 52.61 | — | — | — | — | — | |
| Operating Margin | 11.69 | 6.85 | -23.17 | -2.14 | — | — | — | — | — | |
| Net Margin | -14.99 | -16.25 | -23.99 | -3.33 | — | — | — | — | — | |
| Shares Outstanding | 200 | 199 | 203 | 212 | — | — | — | — | — | |
| Market Capitalization | 1,980 | 2,275 | 3,853 | 7,545 | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| MAZELSKY JONATHAN JAY | Director | Jun 12 '26 | Buy | 10.14 | 10,000 | 101,400 | 61,669 | Jun 18 |
| HOSEIN CLYDE | Director | Jun 15 '26 | Buy | 9.98 | 6,500 | 64,902 | 70,575 | Jun 16 |
| Gladden Brian T | Director | Jun 15 '26 | Buy | 10.02 | 9,985 | 100,000 | 61,849 | Jun 15 |
| MCKEON BRIAN P | Director | Jun 12 '26 | Buy | 10.12 | 10,000 | 101,200 | 10,000 | Jun 15 |
| Barber Michael J | Director | Jun 11 '26 | Buy | 9.88 | 15,175 | 150,005 | 55,943 | Jun 15 |
| HOLDEN BETSY D | Director | Jun 11 '26 | Buy | 9.88 | 10,086 | 99,692 | 87,528 | Jun 15 |
| Forbes James D | Director | Mar 09 '26 | Buy | 12.48 | 5,000 | 62,400 | 10,000 | Mar 09 |
| LUCIER GREGORY T | Director | Mar 09 '26 | Buy | 12.45 | 15,000 | 186,675 | 65,000 | Mar 09 |
| LUCIER GREGORY T | Director | Mar 03 '26 | Buy | 14.03 | 22,445 | 314,858 | 50,000 | Mar 03 |
| Forbes James D | Director | Mar 03 '26 | Buy | 13.47 | 5,000 | 67,345 | 5,000 | Mar 03 |
| LUCIER GREGORY T | Director | Mar 02 '26 | Buy | 14.24 | 27,555 | 392,521 | 27,555 | Mar 03 |
| LUCIER GREGORY T | Director | Dec 08 '25 | Sale | 11.14 | 82,200 | 915,708 | 0 | Dec 10 |
| VARON LESLIE F | Director | Nov 24 '25 | Buy | 10.71 | 9,337 | 99,999 | 57,343 | Nov 25 |
| LUCIER GREGORY T | Director | Mar 03 '25 | Buy | 16.51 | 15,142 | 249,994 | 81,971 | Mar 03 |
| LUCIER GREGORY T | Director | Nov 18 '24 | Buy | 18.37 | 10,000 | 183,700 | 71,730 | Jan 29 |